Detection of hair-microRNAs as the novel potent biomarker: Evaluation of the usefulness for the diagnosis of scleroderma

Journal of Dermatological Science

Volumn 72, Issue 2, 2013, Pages 134-141

  Wang, Zhongzhi ^a   Jinnin, Masatoshi ^a   Kudo, Hideo ^a   Inoue, Kuniko ^a   Nakayama, Wakana ^a   Honda, Noritoshi ^a   Makino, Katsunari ^a   Kajihara, Ikko ^a   Fukushima, Satoshi ^a   Inoue, Yuji ^a   Ihn, Hironobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

3' UTRs; AUCs; CTGF; DcSSc; Hair; IL 17; LcSSc; MicroRNA; MiRNAs; ROC; Scleroderma; SSc; TGF ; TNF

Indexed keywords

MICRORNA; MICRORNA 196A; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN196 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HAIR LEVEL; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; PILOT STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; RNA ANALYSIS; RNA EXTRACTION; RNA ISOLATION; RNA STABILITY; SCLERODERMA; VALIDATION PROCESS; BLOOD; HAIR; HAIR FOLLICLE; METABOLISM; MIDDLE AGED; SCLERODERMA, SYSTEMIC; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION PROFILING; HAIR; HAIR FOLLICLE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC;

EID: 84885076209     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.06.018     Document Type: Article

References (25)

1. Ihn H. Autocrine TGF-β signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci 2008, 49(2):103-113.
2. Mortel M.R., Emer J. Prospective new biologic therapies for psoriasis and psoriatic arthritis. J Drugs Dermatol 2010, 9(8):947-958.
3. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19(1):92-105.
4. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105(30):10513-10518.
5. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N., et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008, 3(9):e3148.
6. Zhu W., Qin W., Atasoy U., Sauter E.R. Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes 2009, 2:89.
7. Kroh E.M., Parkin R.K., Mitchell P.S., Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010, 50(4):298-301.
8. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18(10):997-1006.
9. Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 2008, 3(11):e3694.
10. Valenti R., Huber V., Iero M., Filipazzi P., Parmiani G., Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007, 67(7):2912-2915.
11. Chen X., Liang H., Zhang J., Zen K., Zhang C.Y. Horizontal transfer of microRNAs: molecular mechanisms and clinical applications. Protein Cell 2012, 3(1):28-37.
12. Sing T., Jinnin M., Yamane K., Honda N., Makino K., Kajihara I., et al. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma. Rheumatology (Oxford) 2012, 51(9):1550-1556.
13. Ichihara A., Jinnin M., Oyama R., Yamane K., Fujisawa A., Sakai K., et al. Increased serum levels of miR-1266 in patients with psoriasis vulgaris. Eur J Dermatol 2012, 22(1):68-71.
14. Lefkowitz G.K., Mukhopadhyay A., Cowing-Zitron C., Yu B.D. The post-apoptotic fate of RNAs identified through high-throughput sequencing of human hair. PLoS ONE 2011, 6(11):e27603.
15. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15(2):202-205.
16. Preliminary criteria for the classification of systemic sclerosis (scleroderma) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23(5):581-590.
17. Kanemaru H., Fukushima S., Yamashita J., Honda N., Oyama R., Kakimoto A., et al. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci 2011, 61(3):187-193.
18. Honda N., Jinnin M., Kajihara I., Makino T., Makino K., Masuguchi S., et al. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts. J Immunol 2012, 188(7):3323-3331.
19. Nakashima T., Jinnin M., Etoh T., Fukushima S., Masuguchi S., Maruo K., et al. Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy. PLoS ONE 2010, 5(12):e14334.
20. Redova M., Poprach A., Nekvindova J., Iliev R., Radova L., Lakomy R., et al. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med 2012, 10:55.
21. Chen Y., Li L., Zhou Z., Wang N., Zhang C.Y., Zen K. A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection. Med Microbiol Immunol 2012, 201(3):389-395.
22. LeRoy E.C. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 1974, 54(4):880-889.
23. Jimenez S.A., Feldman G., Bashey R.I., Bienkowski R., Rosenbloom J. Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts. Biochem J 1986, 237(3):837-843.
24. Appaiah H.N., Goswami C.P., Mina L.A., Badve S., Sledge G.W., Liu Y., et al. Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients. Breast Cancer Res 2011, 13(5):R86.
25. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008, 141(5):672-675.